Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1470-2026

Impella RP Flex with SmartAssist. Product Code: 1000323. Recall

Impella RP Flex with SmartAssist. Product Code: 1000323.

FDA recall Class I

Ongoing

FDA lists this Class I recall for Impella RP Flex with SmartAssist. Product Code: 1000323.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1470-2026
Recall classification
Class I
Enforcement status
Ongoing
Initiation date
Jan 27, 2026
FDA report date
Mar 11, 2026
Quantity in commerce
4,496 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Impella RP Flex with SmartAssist. Product Code: 1000323.

Affected model & UDI checker

Search the exact identifiers published for Z-1470-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedImpella RP Flex with SmartAssist. Product Code: 1000323.Check source notice00813502012811
FDA code information

Product Code: 1000323. UDI-DI: 00813502012811.

View the original FDA recall notice

Why was this product recalled?

Differential pressure (dP) sensor in Impella RP devices may malfunction, causing sensor values to drift.

What actions did Abiomed, Inc. take?

Abiomed notified consignees on about 01/27/2026 via UPS delivery. Additionally, the Customer Letter was posted on Heartrecovery.com: https://www.heartrecovery.com/en-us/resources/downloads/field-safety-notification-impella-rp-differential-pressure-sensor. The notifications informed consignees were instructed clinicians that affected units can continue use and they should: 1. Continue to monitor patient hemodynamics with approved diagnostic devices and continue to verify Impella positioning with imaging before clinical interventions. 2. Refer to the P-level flow rates listed in the Instructions for Use (IFUs), as shown in Figure 1, and rely on these values rather than the AIC display. 3. Trend pump metrics to monitor pump performance and to identify sudden change, noting that abrupt changes in the displayed flow rate need to be assessed both against the flow rate listed in the IFU and across temporal trends. Consignees were instructed that product is NOT being removed from the field and does not need to be returned, patients should be assessed with approved diagnostic devices before clinical interventions, complete and return the provided business reply form (BRF) to Abiomed4437@sedgwick, forward the notification to anyone in the facility that needs to be informed (i.e., those who manage, transport, store, stock, or use the subject products) and if any of the subject products have been forwarded to another facility, contact that facility and provide them with this notice.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology